|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Olympus Corporation |
7733.JP |
J61240107 |
2,340 |
$48,636.44 |
2.51% |
| Waters Corporation |
WAT |
941848103 |
144 |
$45,928.80 |
2.37% |
| Terumo Corporation |
4543.JP |
J83173104 |
1,430 |
$45,092.00 |
2.33% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,815 |
$44,758.19 |
2.31% |
| Hologic, Inc. |
HOLX |
436440101 |
568 |
$44,162.00 |
2.28% |
| Masimo Corporation |
MASI |
574795100 |
306 |
$43,216.38 |
2.23% |
| Baxter International Inc. |
BAX |
071813109 |
579 |
$42,400.17 |
2.19% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
732 |
$42,313.58 |
2.19% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,002 |
$41,909.99 |
2.17% |
| Agilent Technologies, Inc. |
A |
00846U101 |
332 |
$41,543.16 |
2.15% |
| Becton, Dickinson and Company |
BDX |
075887109 |
165 |
$41,629.50 |
2.15% |
| Abbott Laboratories |
ABT |
002824100 |
366 |
$41,445.84 |
2.14% |
| Medtronic Plc |
MDT |
G5960L103 |
402 |
$41,217.06 |
2.13% |
| Steris Plc |
STE |
G8473T100 |
182 |
$41,121.08 |
2.13% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
74 |
$41,081.10 |
2.12% |
| Cochlear Limited |
COH.AU |
Q25953102 |
269 |
$40,902.17 |
2.11% |
| Hoya Corporation |
7741.JP |
J22848105 |
394 |
$40,884.47 |
2.11% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
33 |
$40,873.14 |
2.11% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
347 |
$40,810.67 |
2.11% |
| Alcon Inc. |
ALC.SW |
H01301128 |
560 |
$40,394.00 |
2.09% |
| BioMerieux |
BIM.FP |
F1149Y109 |
413 |
$39,888.27 |
2.06% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
76 |
$39,687.20 |
2.05% |
| Boston Scientific Corporation |
BSX |
101137107 |
1,004 |
$39,376.88 |
2.04% |
| NovoCure Limited |
NVCR |
G6674U108 |
525 |
$39,217.50 |
2.03% |
| Stryker Corporation |
SYK |
863667101 |
167 |
$38,785.75 |
2.01% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
594 |
$38,562.48 |
1.99% |
| PerkinElmer, Inc. |
PKI |
714046109 |
262 |
$38,443.26 |
1.99% |
| Danaher Corporation |
DHR |
235851102 |
151 |
$38,021.80 |
1.97% |
| Teleflex Incorporated |
TFX |
879369106 |
132 |
$37,923.60 |
1.96% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,952 |
$37,617.08 |
1.94% |
| The Cooper Companies, Inc. |
COO |
216648402 |
109 |
$37,191.89 |
1.92% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
287 |
$37,005.09 |
1.91% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N119 |
310 |
$36,944.90 |
1.91% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
111 |
$36,810.17 |
1.90% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,478 |
$36,521.97 |
1.89% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,724 |
$36,405.86 |
1.88% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
578 |
$35,968.56 |
1.86% |
| DENTSPLY SIRONA Inc. |
XRAY |
24906P109 |
939 |
$35,447.25 |
1.83% |
| ResMed Inc. |
RMD |
761152107 |
179 |
$35,381.14 |
1.83% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
658 |
$34,985.86 |
1.81% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
365 |
$34,426.80 |
1.78% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
283 |
$34,277.47 |
1.77% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
155 |
$33,955.85 |
1.76% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
105 |
$34,117.76 |
1.76% |
| Insulet Corporation |
PODD |
45784P101 |
169 |
$33,583.68 |
1.74% |
| ABIOMED, Inc. |
ABMD |
003654100 |
142 |
$33,476.50 |
1.73% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
977 |
$32,942.56 |
1.70% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
107 |
$32,172.76 |
1.66% |
| Align Technology, Inc. |
ALGN |
016255101 |
107 |
$29,429.28 |
1.52% |
| DexCom, Inc. |
DXCM |
252131107 |
88 |
$28,268.24 |
1.46% |
| US Dollar |
$USD |
|
7,067 |
$7,066.93 |
0.37% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|